Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Badrivishal Chemicals & Pharmaceuticals is a prominent Indian pharmaceutical manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and fine chemicals. Established in 1991 and headquartered in Pune, the company has gained international recognition as a major producer of Metformin Hydrochloride, a cornerstone treatment for type 2 diabetes. The company operates advanced manufacturing facilities in the Kurkumbh industrial area, which are designed to meet global regulatory standards including WHO-GMP. Badrivishal serves a diverse global clientele, providing high-quality generic drug components and intermediates to the pharmaceutical industry. Their business model focuses on process optimization and large-scale production of essential metabolic health medications. The firm is recognized for its commitment to quality and consistency in the high-volume chemical synthesis of small molecule therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Badrivishal Chemicals & Pharmaceuticals.